-
FDA Approvals Summary - July 2025
FDA Drug Approvals
FDA approved several new drugs in July 2025, including treatments for phenylketonuria, chronic hand eczema, hereditary angioedema, EGFR-mutated lung cancer, and relapsed multiple myeloma, offering new hope for patients.
-
-
-
FDA Approvals Summary - April 2025
FDA Drug Approvals
Discover the FDA's new drug approvals in April 2025, including treatments for IgAN, nasopharyngeal carcinoma, myasthenia gravis, and colorectal cancer. Learn about groundbreaking therapies like Vanrafia, Penpulimab-KCQX, and Imaavy.
-
-
-
-
FDA Approved Summay - Januaray 2025
FDA Drug Approvals
Explore FDA drug approvals from January 2025, including treatments for Crohn's disease, colorectal cancer, Alzheimer's, migraine, and more. Key approvals from Eli Lilly, Amgen, AstraZeneca, and others reshape patient care options.
-
-
FDA 2025 Q1 Approval Overview (I)
FDA Drug Approvals
The FDA's 2025 Q1 approval pipeline includes promising treatments for diabetes, cancer, and central nervous system disorders. Key candidates include Ozempic for kidney disease, Subvenite for epilepsy, and TX05, a HER2-targeted cancer biosimilar.
云南省|
托克托县|
屯门区|
长顺县|
连城县|
花莲县|
枣阳市|
富川|
余江县|
通渭县|
丰县|
延川县|
桐庐县|
墨脱县|
康平县|
西平县|
平罗县|
柳河县|
竹山县|
改则县|
德惠市|
乳山市|
乡城县|
阿克陶县|
阳新县|
黔江区|
尼木县|
科技|
兴化市|
广水市|
松原市|
济源市|
富平县|
托克逊县|
历史|
手机|
大化|
肥乡县|
黔西|
天祝|
岱山县|